We are committed to providing the best treatments for our patients. To do this, we are leading breakthroughs in research to find new and better ways to treat and prevent dementia.
Clinical trials are research studies used to support our mission of finding new and better ways to treat and prevent dementia. With the help of clinical trial volunteers, we can learn more about dementia and provide advanced treatments to current and future patients.
Alzheimer’s disease (diagnosed)
View available trials
COVID-19 survey
View survey
Healthy brain aging (no diagnosis of dementia)
View available trials
Heart health or diagnosis of diastolic dysfunction
View available trials
Memory loss concerns (no diagnosis of dementia)
View available trials
Mild cognitive impairment (diagnosed)
View available trials
Parkinson’s disease (diagnosed)
View available trials
All available clinical trials
View all available trials
We are collaborating with the Multicultural Alzheimer’s Prevention Program (MAPP) at Massachusetts General Hospital to learn more about the general impact of COVID-19 on the well-being, cognition and behavior of Latinos.
The Biggs Institute is an official partner of the Alzheimer’s Disease Cooperative Study and the University of Southern California Alzheimer’s Therapeutic Research Institute.
When a person chooses brain donation, they are choosing to help find better ways to diagnose and treat the 50 million people living with Alzheimer’s disease and other neurodegenerative diseases.
Some of the most exciting advances and discoveries come from studying brain tissue, which is why we need your help.
